Overview

Detailed Summary

Omkar Pharmachem Limited is primarily involved in providing management and business support services within the pharmaceuticals and chemicals industry.
The company, established in 1995, has recently shifted its focus from commercial pharmaceutical activities to offering support services.
Although originally incorporated to operate in the pharmaceuticals and chemicals sector, it has not pursued active commercial operations since incorporation.
There are no active product lines or commercial engagements mentioned, indicating a strategic repositioning towards administrative and support roles within the sector.

Sector: Chemicals & Petrochemicals
Industry: Commodity Chemicals
Market Cap: 17 Cr
Volatility: Low Risk
P/E Ratio: 129.9
Industry P/E: 42.5
PEG Ratio: 44.4
P/B Ratio: 0.5
52W High: 29.74
52W Low: 15.00

Sales CAGR

1Y: —
3Y: —
5Y: 64.38%
10Y: —

Profit CAGR

1Y: 5.26%
3Y: 3.14%
5Y: —
10Y: —

ROE

TTM: 0.33%
3Y: 2.12%
5Y: 2.19%
10Y: 0.18%

ROCE

TTM: 0.45%
3Y: 3.18%
5Y: 2.58%
10Y: 0.55%

Technicals

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Forecasts

Peers

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
KOBO		8.07	19 Cr	-3.82	0.00	0.00	3.71	-72.69	-7.06
TECILCHEM		9.68	18 Cr	-43.69	0.00	0.00	2.27	7.39	-9.70
VENLONPOLY		3.37	18 Cr	-5.21	0.00	0.00	-88.60	-12.91	-7.94
VIVIDIND		18.83	17 Cr	23.23	1.14	0.00	4.58	11.81	1.97
OMKARPH		16.75	17 Cr	129.92	0.46	0.00	0.33	0.45	0.35
SFPIL		8.54	17 Cr	-62.04	0.87	0.00	-1.46	-1.18	-1.28
ADVPETR-B		164.30	15 Cr	739.50	3.72	0.00	0.72	6.65	0.06
Median: 7 Co.	—	9.68	17 Cr	-3.82	0.46	0.00	0.72	0.45	-1.28

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.11	0.09
Expenses	0.07	0.06	0.09	0.05	0.05	0.07	0.10	0.07	0.07	0.07
Operating Profit	0.07	0.08	0.05	0.09	0.09	0.07	0.04	0.07	0.04	0.02
OPM %	50.00	57.14	35.71	64.29	64.29	50.00	28.57	50.00	36.36	22.22
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.03	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	0.07	0.05	0.05	0.09	0.08	0.05	0.04	0.07	0.04	0.02
Tax %	0.00	120.00	0.00	0.00	0.00	140.00	25.00	28.57	25.00	0.00
Net Profit	0.07	-0.02	0.05	0.09	0.08	-0.02	0.03	0.05	0.03	0.02
EPS in Rs	0.07	-0.02	0.05	0.09	0.08	-0.02	0.03	0.05	0.03	26.87

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	0.00	0.00	0.00	0.05	0.27	0.54	0.54	0.54	0.54	0.56
Expenses	0.22	0.24	0.38	0.25	0.25	0.27	0.23	0.26	0.25	0.27
Operating Profit	-0.22	-0.24	-0.38	-0.20	0.02	0.27	0.31	0.28	0.29	0.29
OPM %	—	—	—	-454.22	8.07	49.67	57.50	52.46	53.70	51.79
Other Income	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	NaN
Interest	0.00	0.01	0.04	0.05	0.06	0.06	0.05	0.03	0.02	0.02
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00
Profit Before Tax	0.27	-0.25	-0.42	-0.26	-0.04	0.21	0.26	0.25	0.27	0.26
Tax %	18.13	-1.23	0.10	0.00	716.71	13.02	25.22	25.20	25.59	30.77
Net Profit	0.22	-0.26	-0.42	-0.26	0.22	0.18	0.20	0.19	0.20	0.18
EPS in Rs	0.22	-0.25	-0.42	-0.17	0.22	0.18	0.20	0.19	0.20	26.98
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	10	10	10	10	10	10	10	10	10	10
Reserves	-0.93	-0.71	-0.96	-1.38	-1.64	-1.42	-1.24	-1.04	-0.85	-0.65
Borrowings	0.00	0.00	0.24	0.58	0.87	0.90	0.93	0.62	0.30	0.12
Other Liabilities	0.56	0.05	0.04	0.05	0.06	0.07	0.05	0.06	0.06	0.05
Total Liabilities	9.72	9.43	9.40	9.32	9.36	9.63	9.83	9.73	9.59	9.60
Fixed Assets	0.01	0.00	0.01	0.00	0.00	0.00	0.01	0.00	0.01	0.01
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	9.30	9.30	9.30	9.30	9.30	9.30	9.30	9.30	9.30	9.30
Other Assets	0.41	0.13	0.10	0.02	0.06	0.33	0.52	0.43	0.28	0.30
Total Assets	9.72	9.43	9.40	9.32	9.36	9.63	9.83	9.73	9.59	9.60

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.34	-0.77	-0.25	-0.30	-0.21	0.02	0.20	—	—	0.24
Cash from Investing Activity	0.00	0.49	-0.01	0.00	-0.00	0.00	-0.01	0.00	0.00	-0.00
Cash from Financing Activity	-0.01	0.01	0.23	0.30	0.24	-0.02	-0.03	—	—	-0.20
Net Cash Flow	0.33	-0.28	-0.03	0.00	0.02	0.00	0.17	0.00	0.00	0.04

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	99.97%	99.97%	99.97%	99.97%	99.97%	99.97%	99.97%	99.97%	99.97%	99.97%	99.97%	99.97%
Total Shareholders	3,590	3,600	3,601	3,609	3,608	3,609	3,611	3,619	3,618	3,618	3,617	3,669

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Omkar Pharmachem Ltd

Omkar Pharmachem Ltd (OMKARPH) is currently trading at 16.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Omkar Pharmachem Limited is primarily involved in providing management and business support services within the pharmaceuticals and chemicals industry. The company, established in 1995, has recently shifted its focus from commercial pharmaceutical activities to offering support services. Although originally incorporated to operate in the pharmaceuticals and chemicals sector, it has not pursued active commercial operations since incorporation. There are no active product lines or commercial engagements mentioned, indicating a strategic repositioning towards administrative and support roles within the sector.

Over the past 52 weeks, Omkar Pharmachem Ltd has traded between a low of ₹15.00 and a high of ₹29.74. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Omkar Pharmachem Ltd has a market capitalization of approximately 16.89. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Omkar Pharmachem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 129.92 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 16.89 Cr, Omkar Pharmachem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Omkar Pharmachem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Omkar Pharmachem Ltd is 129.92. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Omkar Pharmachem Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Oscillators

Neutral

Overall

Neutral

Moving Averages

Neutral

Overall

Neutral

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Omkar Pharmachem Ltd

What is Omkar Pharmachem Ltd share price today?

What does Omkar Pharmachem Ltd do?

What is the 52-week high and low of Omkar Pharmachem Ltd?

What is the market capitalization of Omkar Pharmachem Ltd?

Should I consider investing in Omkar Pharmachem Ltd stock?

Is Omkar Pharmachem Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Omkar Pharmachem Ltd belong to and why does it matter?

What is the PE ratio of Omkar Pharmachem Ltd?

Investor's Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Overview

Financial Ratios

Forecasts

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Frequently Asked Questions about Omkar Pharmachem Ltd

What is Omkar Pharmachem Ltd share price today?

What does Omkar Pharmachem Ltd do?

What is the 52-week high and low of Omkar Pharmachem Ltd?

What is the market capitalization of Omkar Pharmachem Ltd?

Should I consider investing in Omkar Pharmachem Ltd stock?

Is Omkar Pharmachem Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Omkar Pharmachem Ltd belong to and why does it matter?

What is the PE ratio of Omkar Pharmachem Ltd?

Investment Checklist

Peers

Price Chart Comparison

Announcements